Serum Institute of India was on the verge of signing a billion-dollar agreement with a clutch of marquee global investors last year but withdrew at the last minute even as it struggled to scale up production of COVID-19 vaccines due to an apparent lack of funds, said two people directly aware of the matter.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com